Building collaborations to fight a pandemic
The Pharma Data
AUGUST 21, 2020
When COVID-19 began to emerge – first in Asia, then in Europe – she could see that its relative ease transmitting from person to person, along with the lack of tests and preventions or treatments for infection, made the virus a credible threat to humanity. What factors do you weigh when deciding whether to join a consortium? Source link.
Let's personalize your content